TipRanks

David Hung Insider Profile

18 Followers
David Hung, Director at NovoCure, holds 32.08K shares in NovoCure (Ticker: NVCR), holds ― shares in Establishment Labs Holdings (Ticker: ESTA), holds ― shares in ARYA Sciences Acquisition (Ticker: ~ARYA).
tipranks
David Hung

David Hung
NovoCure (NVCR)
Director

Ranked #7,932 out of 109,106 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+78.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$360M
99.85%
0.15%
0.00%
A breakdown of David Hung's holdings

Insider Roles

Nuvation Bio
(NUVB)
President & CEO, Director, Ten Percent Owner
NovoCure
(NVCR)
Director
Establishment Labs Holdings
(ESTA)
Director
Roles that David Hung holds in companies

Most Profitable Insider Trade

Stock:
Nuvation Bio
(NUVB)
Rating:Informative Buy
Date:Jun 18, 2025 - Jun 18, 2026
Return:+210.60%
The most profitable trade made by David Hung

David Hung's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NovoCure
Jun 05, 2026
Director
Uninformative Buy
$530.20K
Establishment Labs Holdings
Director
~ARYA
ARYA Sciences Acquisition
Nuvation Bio
Jun 18, 2025
President & CEO, Director, Ten Percent Owner
Informative Buy
890.00K
$359.84M
MDVN
Medivation
Sep 30, 2016
Uninformative Sell
$133.32M
SIOX
Sio Gene Therapies
Apr 19, 2017
Informative Buy
10.00M
$0.00
ACER
Acer Therapeutics
Sep 10, 2009
Informative Sell
84.44K
$0.00
List of latest transactions for each holding click on a transaction to see David Hung's performance on stock

David Hung insider profile FAQ

What is the percentage of profitable transactions made by David Hung?
The percentage of profitable transactions made by David Hung is 75%.
    What is the average return per transaction made by David Hung?
    The average return per transaction made by David Hung is 78.20%.
      What stocks does David Hung hold?
      David Hung holds: NVCR, ESTA, ~ARYA, NUVB, MDVN, SIOX, ACER stocks.
        What was David Hung’s latest transaction?
        David Hung latest transaction was an Uninformative Buy of ―.
          What was David Hung's most profitable transaction?
          David Hung’s most profitable transaction was an Informative Buy of NUVB stock on June 18, 2025. The return on the trade was 210.60%.
            What is David Hung's role in NovoCure?
            David Hung's role in NovoCure is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.